Winter is coming, and for adventure travelers this means gearing up and booking flights to mountain hubs and ski-towns. But unpredictable winter weather can mean delays and cancellations that ripple through key airports. To help winter travelers plan smarter, the experts at SOVENTURE reviewed Department of Transportation data to highlight U.S. airports most and least […]

Tax Guard and SPARK's partnership will help streamline the lending process. Tax Guard, a Cogency Global company and the first provider of real-time IRS tax data services, has partnered with SPARK, a faster, simpler loan origination platform for the digital age. The partnership will improve lenders' access to high quality tax data, helping them make

Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of

Pomerantz LLP announces that a class action lawsuit has been filed againstFortinet, Inc. (“Fortinet” or the “Company”)(NASDAQ: FTNT). Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The

Pomerantz LLP announces that a class action lawsuit has been filed against Lantheus Holdings, Inc. (“Lantheus” or the “Company”)(NASDAQ: LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares

Pomerantz LLP announces that a class action lawsuit has been filed against Semler Scientific, Inc. (“Semler” or the “Company”)(NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares

York, Pa., Oct. 23, 2025 (GLOBE NEWSWIRE) — WellSpan Health president and CEO Roxanna Gapstur, Ph.D., R.N., has been named one of nine women inductees as a Distinguished Daughter of Pennsylvania for 2025. Gapstur was recognized recently at an event alongside other honorees for their professional achievements and volunteer service that have a tremendous impact

Pomerantz LLP announces that a class action lawsuit has been filed against Cepton, Inc. (“Cepton” or the “Company”) (NASDAQ: CPTN) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08571, is on behalf of a class consisting of all persons and entities

(NASDAQ:IMNN), IMNN-001 program is currently advancing its OVATION 3 pivotal Phase 3 trial per plan LAWRENCEVILLE, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that new translational data from the Phase 2 OVATION 2 clinical trial of IMNN-001, its

Pomerantz LLP is investigating claims on behalf of investors of Exelixis, Inc. (“Exelixis” or the “Company”) (NASDAQ: EXEL).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Exelixis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for